Stock data
Harvard Bioscience, Inc. (HBIO)
Harvard Bioscience, Inc. (HBIO) reported revenue of US$86.55M and net income of -US$56.70M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$86.55M | US$49.91M | -US$48.58M | -US$56.70M | — |
| 2024 | US$94.14M | US$54.77M | -US$6.21M | -US$12.40M | — |
| 2023 | US$112.25M | US$66.07M | US$1.89M | -US$3.42M | — |
| 2022 | US$113.33M | US$60.82M | -US$6.93M | -US$9.52M | — |
| 2021 | US$118.90M | US$67.65M | US$2.07M | -US$0.29M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$22.73M | -US$2.91M | — |
| 2026-03-31 | US$20.75M | -US$3.42M | — |
| 2025-12-31 | US$23.73M | -US$2.85M | — |
| 2025-09-30 | US$20.59M | -US$1.23M | — |
| 2025-06-30 | US$20.45M | -US$2.28M | — |
| 2025-03-31 | US$21.77M | -US$50.34M | — |
| 2024-12-31 | US$24.56M | US$0.02M | — |
| 2024-09-30 | US$21.97M | -US$4.80M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.